Useful proposal for a critical appraisal tool for Delphi studies
https://www.bmj.com/content/391/bmj-2025-084509
Ironically, the proposed tool was developed w/o consultation, #SysReview, or consensus methods.
Opportunity to point to a very good reporting guideline for Delphi studies:
https://pubmed.ncbi.nlm.nih.gov/35718726/
A #SysReview exploring impacts of community-based interventions for adults with #multimorbidity on clinical and patient-reported outcomes (25 studies):
https://bmjpublichealth.bmj.com/content/4/1/e004156
Quick comparison of identified outcomes with the two central #CoreOutcomeSets 👇
Quality Assessment of Diagnostic Test Accuracy Studies
QUADAS-3 published:
https://pubmed.ncbi.nlm.nih.gov/41698208/
__Key changes from QUADAS-2__
introduction of an 'ideal test accuracy trial'
assessment at the estimate rather than study level
"Flow and Timing" domain replaced with an "Analysis" domain
sections on the rationale for judgments
introduction of a judgment of #RiskOfBias and concerns regarding applicability
We* investigated how QoL/ #HRQoL instruments were used as outcome measures in substance and behavioural addictions. We found similar issues as this team regarding wide variety of measures, lack of theory, and issues around methodological quality:
https://onlinelibrary.wiley.com/doi/10.1111/dar.13717
Brittany Lapin and I edited* the joint publication of the PRISMA-COSMIN guidelines for Outcome Measurement Instruments 2024 in four journals last year:
https://pubmed.ncbi.nlm.nih.gov/38980635/
It is great to see that this is now also accompanied by table templates for communication of results
https://link.springer.com/article/10.1007/s11136-025-04058-y
#NightshiftEditor #ReportingGuidelines #AcademicPublishing #SysReview #Psychometrics
* https://osf.io/preprints/osf/ukw93_v1
PRISMA-COSMIN for OMIs 2024 consists of two checklists (full reports; abstracts), their corresponding explanation and elaboration documents detailing the rationale and examples for each item, and a data flow diagram. PRISMA-COSMIN for OMIs 2024 can improve the reporting of systematic reviews of OMIs …
Brittany Lapin and I edited* the joint publication of the PRISMA-COSMIN guidelines for Outcome Measurement Instruments 2024 in four journals last year:
https://pubmed.ncbi.nlm.nih.gov/38980635/
It is great to see that this is now also accompanied by table templates for communication of results
https://link.springer.com/article/10.1007/s11136-025-04058-y
#NightshiftEditor #ReportingGuidelines #AcademicPublishing #SysReview #Psychometrics
* https://osf.io/preprints/osf/ukw93_v1
PRISMA-COSMIN for OMIs 2024 consists of two checklists (full reports; abstracts), their corresponding explanation and elaboration documents detailing the rationale and examples for each item, and a data flow diagram. PRISMA-COSMIN for OMIs 2024 can improve the reporting of systematic reviews of OMIs …
Busy week, I have not much posted from #RSS2025. This will follow in the next days.
For now, I enjoyed chatting with Robert Grant and am reading his co-authored book "Bayesian #MetaAnalysis" which he kindly gave me a copy of 🙇
http://www.robertgrantstats.co.uk/bma-book.html
I am always looking combinations of unusual and cross-cutting themes for teaching/ training, so I'll do a parallel read with #MixtureModels in this area: https://link.springer.com/chapter/10.1007/978-3-540-68651-4_7
First up, @ptoner.bsky.social presents on developing screening & assessment instruments for young people.
Currently available from this work #SysReview -s on
https://www.sciencedirect.com/science/article/pii/S0376871619300626?via%3Dihub
and work on #HRQoL assessment
https://onlinelibrary.wiley.com/doi/10.1111/dar.13717
A #SysReview of quality of life and #HRQoL instruments used in trials of interventions for adults with alcohol use disorder:
https://www.jsatjournal.com/article/S2949-8759(25)00172-9/fulltext
One of the interesting findings:
Although the team focused on the most frequently used instruments they found only very few studies reporting psychometric properties in this population.
This mirrors findings from our broader #SysReview of #HRQL as an outcome in substance and behavioural addictions
https://pubmed.ncbi.nlm.nih.gov/37439397/
This #SysReview suggests that medical #crowdfunding is less a tool for mitigating health disparities, but rather reproduces existing #HealthInequity.
Individuals who face structural barriers to healthcare access often have the greatest financial need but the least capacity to launch successful campaigns.
https://equityhealthj.biomedcentral.com/articles/10.1186/s12939-025-02543-x
Background Medical crowdfunding has emerged as a popular strategy to offset healthcare expenses in contexts of limited insurance coverage. While often framed as a democratizing and accessible financial tool, growing evidence indicates that success is unevenly distributed, raising concerns about its role in exacerbating health inequities. Methods A systematic review was conducted in accordance with PRISMA guidelines, drawing from PubMed, CINAHL, Embase, Web of Science, and Scopus. Of 1,462 screened records, 33 studies met the inclusion criteria. Guided by the PROGRESS framework, we extracted data on socioeconomic determinants of health disparities. An inductive content analysis was employed to identify how equity was assessed across studies. Results We identified three key categories of metrics used to assess equity in medical crowdfunding: funding outcomes, campaign visibility, and donor participation. Across these domains, substantial disparities were observed. Campaigns in rural or economically disadvantaged areas tended to have lower success rates. Racial and ethnic inequities were consistently documented, with non-white individuals receiving fewer and smaller donations than white counterparts. Gender disparities were complex, especially in transgender-related campaigns. Socioeconomic status and educational attainment were significantly associated with outcomes, accompanied by differences in access to social capital and the ability to craft persuasive narratives. In regions with high medical debt or limited insurance coverage, more crowdfunding campaigns appeared, but with lower overall success. These inequities were shaped and reinforced by platform algorithms and design features that privileged users with preexisting advantages. Conclusions Rather than serving as a corrective to healthcare access gaps, medical crowdfunding often reflects and reinforces structural inequities. These findings challenge its portrayal as an equitable financing solution and highlight the need for policy interventions to ensure fairer access to healthcare resources.
Jan R. Boehnke